Cover Image
市場調查報告書

輻射免疫檢測的全球市場的預測 ∼2020年:各類型 (試劑&套件、分析儀)、終端用戶、用途 (研究、臨床診斷)、地區

Radioimmunoassay Market by Type (Reagents & Kits, Analyzers), End User (Hospital, Pharmaceutical Industry, Academics, Clinical Diagnostic Labs), Application (Research, Clinical Diagnostics), and Geography - Global Forecast to 2020

出版商 MarketsandMarkets 商品編碼 342322
出版日期 內容資訊 英文 115 Pages
訂單完成後即時交付
價格
Back to Top
輻射免疫檢測的全球市場的預測 ∼2020年:各類型 (試劑&套件、分析儀)、終端用戶、用途 (研究、臨床診斷)、地區 Radioimmunoassay Market by Type (Reagents & Kits, Analyzers), End User (Hospital, Pharmaceutical Industry, Academics, Clinical Diagnostic Labs), Application (Research, Clinical Diagnostics), and Geography - Global Forecast to 2020
出版日期: 2015年10月20日 內容資訊: 英文 115 Pages
簡介

全球輻射免疫檢測市場,預計從2015年到2020年以3.5%的年複合成長率發展,2020年成長到4億2840萬美元的規模。高齡化的進展和癌症領域的輻射免疫檢測 技術的利用擴大成為該市場的主要的推進因素。

本報告提供全球輻射免疫檢測的市場相關調查、輻射免疫檢測 (RIA) 的概要與免疫檢測市場與比較、市場的各種影響因素分析、各類型/終端用戶/用途的主要趨勢與市場規模的變化與預測、各地區及主要國家分析、競爭環境與市場佔有率,以及主要企業的簡介等彙整。

第1章 簡介

第2章 調查手法

第3章 摘要整理

第4章 市場概要

  • 簡介
  • 輻射免疫檢測 (RIA) 市場:免疫檢測市場與比較
  • 市場促進因素、阻礙要素

第5章 市場分析:各類型

  • 簡介
  • 試劑、套件
  • 分析儀

第6章 市場分析:各終端用戶

  • 簡介
  • 醫院
  • 醫藥品產業、CRO
  • 學術機構
  • 臨床診斷實驗室

第7章 市場分析:各用途

  • 簡介
  • 研究
  • 臨床診斷

第8章 地區分析

  • 簡介
  • 歐洲
    • 各類型
    • 各用途
    • 各終端用戶
    • 各國
      • 德國
      • 法國
      • 英國
      • 義大利
      • 西班牙
  • 北美
    • 各類型
    • 各用途
    • 各終端用戶
    • 各國
      • 美國
      • 加拿大
      • 墨西哥
  • 亞洲
    • 各類型
    • 各用途
    • 各終端用戶
    • 各國
      • 中國
      • 日本
      • 印度
      • 韓國
  • 其他地區
    • 各類型
    • 各用途
    • 各終端用戶

第9章 競爭環境

  • 市場佔有率分析

第10章 企業簡介

  • DIASORIN S.P.A.
  • EURO DIAGNOSTICA AB
  • MERCK MILLIPORE CORPORATION
  • DIASOURCE IMMUNOSSAYS S.A
  • STRATEC BIOMEDICALS AG
  • BERTHOLD TECHNOLOGIES GMBH & CO. KG
  • IZOTOP
  • BECKMAN COULTER, INC.
  • CISBIO
  • MP BIOMEDICALS LLC
  • PERKINELMER, INC.
  • IBL INTERNATIONAL (A TECAN COMPANY)
  • DRG INTERNATIONAL, INC.
    • 產業概要
    • 產品與服務
    • 主要的發展趨勢
    • MNN的見解等

第11章 附錄

圖表

目錄
Product Code: MD 3826

Radioimmunoassay Market by Type (Reagents & Kits, Analyzers), by Application (Research, Clinical Diagnostics), by End User (Hospitals, Pharmaceutical Industry & CROs, Academics, Others), by Geography- Global Forecast to 2020.

Radioimmunoassay technique is basically used to measure the concentration of specific antigens by using specific antibodies. This technique is mainly used for research purposes rather than for diagnostics purposes. The global radioimmunoassay (RIA) market constituted 2.3% share of the global immunoassay market.

Radioimmunoassay has applications in the field of clinical diagnostics, and is used in hospitals, contract research organizations (CRO), laboratories, pharmaceutical companies, and others. It is used for the early detection and diagnosis of cancer; recognition of endocrinological disorders; and various other applications. Pharmaceuticals companies use the RIA techniques for drug testing. Radioimmunoassay also has it application in the research purpose, and contributed a share of 65.9% to the overall radioimmunoassay market in 2014.

The global radioimmunoassay market is expected to reach $428.4 million by 2020, at a CAGR of 3.5% during the forecast period from 2015 to 2020. The growing aging population and rise in the usage of radioimmunoassay technique in Oncology are the major factors influencing this market.

There are various application areas for RIA in research and diagnostics, which are infectious disease testing, endocrine testing, allergy testing, oncology testing, toxicology testing, and autoimmune disease testing. Out of all the application segments, oncology testing is the largest application segment, and is expected to hold the largest market share in the near future. The major reason behind these is the growth in the oncology market due to various factors, such as the increasing incidence rate of cancer, growth in aging population, urbanization with heavy pollution, and others.

The global radioimmunoassay market report studies the major regions, namely, North America, Europe, Asia, and the Rest of the World (RoW).

In 2015, Europe is estimated to account for the largest share of 35.1% in the global radioimmunoassay market. As radioimmunoassay is one of the key instruments used in the life sciences sector, increased investments in life sciences are expected to fuel the growth of the radioimmunoassay market in the region. However, the growth in the European radioimmunoassay market is driven by the outsourcing of drug discovery, rising government investments in life sciences, and increasing prevalence of infectious diseases as well as cancer in this region.

The report includes company profiles of major players, recent activities in the market, new product launches, mergers & acquisitions, collaborations and partnerships, and SWOT analysis. Some of the companies profiled in this report are DIAsource ImmunoAssays SA (Belgium), Beckman Coulter, Inc. (U.S.), IBL International (A Tecan Company) (Germany), PerkinElmer, Inc. (U.S.), DRG International, Inc. (U.S.), MP Biomedicals, LLC (U.S.), Cisbio (France), Euro Diagnostica AB (Sweden), DiaSorin S.p.A.. (Italy), EMD Millipore (U.S.), Izotop (Hungary), Berthold Technologies GmbH & Co. KG (Germany), and Stratec Biomedical AG (Germany), among others.

Reasons to Buy the Report:

From an insight perspective, this research report has focused on various levels of analysis, namely, industry analysis (industry trends and PEST analysis), market share analysis of top players, supply chain analysis, and company profiles. All of these together comprise and discuss the basic views on the competitive landscape, usage patterns, emerging- and high-growth segments, high-growth regions and countries and their respective regulatory policies, government initiatives, drivers, restraints, and opportunities of the global Radioimmunoassay (RIA) market.

The report will enrich both established firms as well as new entrants/smaller firms to gauge the pulse of the market, which in turn will help the firms in garnering a greater market share. Firms purchasing the report could use any one or a combination of the below mentioned five strategies to strengthen their market share.

The report provides insights on the following pointers:

  • Product Analysis and Development: Detailed insights on upcoming technologies, research and development activities, and new product launches in the Global Radioimmunoassay (RIA) market are provided.
  • Market Development: Comprehensive information about lucrative emerging markets is provided. The report also analyzes the markets for Radioimmunoassay (RIA) across various regions, exploit new distribution channels, new clientele base and different pricing policies.
  • Market Diversification: Exhaustive information about new products, untapped geographies, recent developments, and investments decisions in the Global Radioimmunoassay (RIA) market is provided. Detailed description regarding the related and unrelated diversification pertaining to this market is also provided.
  • Competitive Assessment: An in-depth assessment of market shares and company share analysis of the key players forecasted till 2020 is provided. Develop business strategies and manufacturing capabilities of leading players enhance the bottom line of the companies in the Radioimmunoassay (RIA) market.

TABLE OF CONTENTS

1. INTRODUCTION

  • 1.1. OBJECTIVES OF THE STUDY
  • 1.2. MARKET SEGMENTATION & COVERAGE
  • 1.3. STAKEHOLDERS

2. RESEARCH METHODOLOGY

  • 2.1. INTEGRATED ECOSYSTEM OF THE RADIOIMMUNOASSAY (RIA) MARKET
  • 2.2. ARRIVING AT THE RADIOIMMUNOASSAY (RIA) MARKET SIZE
    • 2.2.1. TOP-DOWN APPROACH
    • 2.2.2. MACRO INDICATOR-BASED APPROACH
  • 2.3. ASSUMPTIONS

3. EXECUTIVE SUMMARY

4. MARKET OVERVIEW

  • 4.1. INTRODUCTION
  • 4.2. RADIOIMMUNOASSAY (RIA) MARKET: COMPARISON WITH IMMUNOASSAY MARKET (PARENT MARKET)
  • 4.3. MARKET DRIVERS AND INHIBITORS

5. RADIOIMMUNOASSAY (RIA) MARKET, BY TYPE

  • 5.1. INTRODUCTION
  • 5.2. REAGENTS & KITS MARKET
  • 5.3. ANALYZERS MARKET

6. RADIOIMMUNOASSAY (RIA) MARKET, BY END USER

  • 6.1. INTRODUCTION
  • 6.2. HOSPITAL
  • 6.3. PHARMACEUTICAL INDUSTRY AND CRO
  • 6.4. ACADEMICS
  • 6.5. CLINICAL DIAGNOSTIC LABORATORIES

7. RADIOIMMUNOASSAY (RIA) MARKET, BY APPLICATION

  • 7.1. INTRODUCTION
  • 7.2. RESEARCH
  • 7.3. CLINICAL DIAGNOSTICS

8. RADIOIMMUNOASSAY MARKET, BY GEOGRAPHY

  • 8.1. INTRODUCTION
  • 8.2. EUROPE
    • 8.2.1. BY TYPE
    • 8.2.2. BY APPLICATION
    • 8.2.3. BY END USER
    • 8.2.4. BY COUNTRY
      • 8.2.4.1. GERMANY
      • 8.2.4.2. FRANCE
      • 8.2.4.3. U.K.
      • 8.2.4.4. ITALY
      • 8.2.4.5. SPAIN
  • 8.3. NORTH AMERICA
    • 8.3.1. BY TYPE
    • 8.3.2. BY APPLICATION
    • 8.3.3. BY END USER
    • 8.3.4. BY COUNTRY
      • 8.3.4.1. U.S.
      • 8.3.4.2. CANADA
      • 8.3.4.3. MEXICO
  • 8.4. ASIA
    • 8.4.1. BY TYPE
    • 8.4.2. BY APPLICATION
    • 8.4.3. BY END USER
    • 8.4.4. BY COUNTRY
      • 8.4.4.1. CHINA
      • 8.4.4.2. JAPAN
      • 8.4.4.3. INDIA
      • 8.4.4.4. REPUBLIC OF KOREA
  • 8.5. REST OF THE WORLD (ROW)
    • 8.5.1. BY TYPE
    • 8.5.2. BY APPLICATION
    • 8.5.3. BY END USER

9. COMPETITIVE LANDSCAPE

  • 9.1. COMPANY SHARE ANALYSIS

10. COMPANY PROFILES (Business Overview, Products & Services, Key Insights, Recent Developments, MnM View)*

  • 10.1. DIASORIN S.P.A.
  • 10.2. EURO DIAGNOSTICA AB
  • 10.3. MERCK MILLIPORE CORPORATION
  • 10.4. DIASOURCE IMMUNOSSAYS S.A
  • 10.5. STRATEC BIOMEDICALS AG
  • 10.6. BERTHOLD TECHNOLOGIES GMBH & CO. KG
  • 10.7. IZOTOP
  • 10.8. BECKMAN COULTER, INC.
  • 10.9. CISBIO
  • 10.10. MP BIOMEDICALS LLC
  • 10.11. PERKINELMER, INC.
  • 10.12. IBL INTERNATIONAL (A TECAN COMPANY)
  • 10.13. DRG INTERNATIONAL, INC.

*Details on Business Overview, Products & Services, Key Insights, Recent Developments, MnM View might not be captured in case of unlisted companies.

11. APPENDIX

  • 11.1. CUSTOMIZATION OPTIONS
    • 11.1.1. PRODUCT ANALYSIS
    • 11.1.2. BRAND/PRODUCT PERCEPTION MATRIX
    • 11.1.3. PORTER'S FIVE FORCES ANALYSIS
  • 11.2. RELATED REPORTS

LIST OF TABLES

  • TABLE 1: IMMUNOASSAY MARKET SIZE & RADIOIMMUNOASSAY MARKET SIZE, 2014 (USD MILLION)
  • TABLE 2: RADIOIMMUNOASSAY (RIA) MARKET: COMPARISON WITH IMMUNOASSAY MARKET (PARENT MARKET), 2013-2020 (USD MILLION)
  • TABLE 3: RADIOIMMUNOASSAY (RIA) MARKET, BY TYPE, 2013-2020 (USD MILLION)
  • TABLE 4: RADIOIMMUNOASSAY (RIA) MARKET, BY END-USER , 2013-2020 (USD MILLION)
  • TABLE 5: RADIOIMMUNOASSAY (RIA) MARKET, BY APPLICATION, 2013-2020 (USD MILLION)
  • TABLE 6: RADIOIMMUNOASSAY MARKET, BY GEOGRAPHY, 2013-2020 (USD MILLION)
  • TABLE 7: RADIOIMMUNOASSAY (RIA) MARKET: DRIVERS AND INHIBITORS
  • TABLE 8: RADIOIMMUNOASSAY MARKET, BY TYPE, 2013-2020 (USD MILLION)
  • TABLE 9: RADIOIMMUNOASSAY (RIA) REAGENTS & KITS MARKET, BY GEOGRAPHY, 2013-2020 (USD MILLION)
  • TABLE 10: RADIOIMMUNOASSAY (RIA) ANALYZERS MARKET, BY GEOGRAPHY, 2013-2020 (USD MILLION)
  • TABLE 11: RADIOIMMUNOASSAY (RIA) MARKET, BY END-USERS, 2013-2020 (USD MILLION)
  • TABLE 12: RADIOIMMUNOASSAY (RIA) MARKET IN HOSPITALS, BY GEOGRAPHY, 2013-2020 (USD MILLION)
  • TABLE 13: RADIOIMMUNOASSAY (RIA) MARKET IN PHARMACEUTICAL INDUSTRY AND CRO, BY GEOGRAPHY, 2013-2020 (USD MILLION)
  • TABLE 14: RADIOIMMUNOASSAY (RIA) MARKET IN ACADEMICS, BY GEOGRAPHY, 2013-2020 (USD MILLION)
  • TABLE 15: RADIOIMMUNOASSAY (RIA) MARKET IN CLINICAL DIAGNOSTIC LABORATORIES, BY GEOGRAPHY, 2013-2020 (USD MILLION)
  • TABLE 16: RADIOIMMUNOASSAY (RIA) MARKET, BY APPLICATION, 2013-2020 (USD MILLION)
  • TABLE 17: RADIOIMMUNOASSAY (RIA) MARKET IN RESEARCH, BY GEOGRAPHY, 2013-2020 (USD MILLION)
  • TABLE 18: RADIOIMMUNOASSAY (RIA) ANALYZERS MARKET IN RESEARCH APPLICATION, BY GEOGRAPHY, 2013-2020 (USD MILLION)
  • TABLE 19: RADIOIMMUNOASSAY (RIA) KITS & REAGENTS MARKET IN RESEARCH APPLICATION, BY GEOGRAPHY, 2013-2020 (USD MILLION)
  • TABLE 20: RADIOIMMUNOASSAY (RIA) MARKET IN CLINICAL DIAGNOSTICS, BY GEOGRAPHY, 2013-2020 (USD MILLION)
  • TABLE 21: RADIOIMMUNOASSAY (RIA) ANALYZERS MARKET IN CLINICAL DIAGNOSTICS APPLICATION, BY GEOGRAPHY, 2013-2020 (USD MILLION)
  • TABLE 22: RADIOIMMUNOASSAY (RIA) KITS & REAGENTS MARKET IN CLINICAL DIAGNOSTICS APPLICATION, BY GEOGRAPHY, 2013-2020 (USD MILLION)
  • TABLE 23: RADIOIMMUNOASSAY (RIA) MARKET, BY GEOGRAPHY, 2013-2020 (USD MILLION)
  • TABLE 24: EUROPE RADIOIMMUNOASSAY (RIA) MARKET, BY TYPE, 2013-2020 (USD MILLION)
  • TABLE 25: EUROPE RADIOIMMUNOASSAY (RIA) MARKET, BY APPLICATION, 2013-2020 (USD MILLION)
  • TABLE 26: EUROPE RADIOIMMUNOASSAY (RIA) ANALYZERS MARKET, BY APPLICATION, 2013-2020 (USD MILLION)
  • TABLE 27: EUROPE RADIOIMMUNOASSAY (RIA) REAGENTS & KITS MARKET, BY APPLICATION, 2013-2020 (USD MILLION)
  • TABLE 28: EUROPE RADIOIMMUNOASSAY (RIA) MARKET, BY END USER, 2013-2020 (USD MILLION)
  • TABLE 29: GERMANY RADIOIMMUNOASSAY (RIA) MARKET, BY TYPE, 2013-2020 (USD MILLION)
  • TABLE 30: GERMANY RADIOIMMUNOASSAY (RIA) MARKET, BY APPLICATION, 2013-2020 (USD MILLION)
  • TABLE 31: FRANCE RADIOIMMUNOASSAY (RIA) MARKET, BY TYPE, 2013-2020 (USD MILLION)
  • TABLE 32: FRANCE RADIOIMMUNOASSAY (RIA) MARKET, BY APPLICATION, 2013-2020 (USD MILLION)
  • TABLE 33: U.K. RADIOIMMUNOASSAY (RIA) MARKET, BY TYPE, 2013-2020 (USD MILLION)
  • TABLE 34: U.K. RADIOIMMUNOASSAY (RIA) MARKET, BY APPLICATION, 2013-2020 (USD MILLION)
  • TABLE 35: ITALY RADIOIMMUNOASSAY (RIA) MARKET, BY TYPE, 2013-2020 (USD MILLION)
  • TABLE 36: ITALY RADIOIMMUNOASSAY (RIA) MARKET, BY APPLICATION, 2013-2020 (USD MILLION)
  • TABLE 37: SPAIN RADIOIMMUNOASSAY (RIA) MARKET, BY TYPE, 2013-2020 (USD MILLION)
  • TABLE 38: SPAIN RADIOIMMUNOASSAY (RIA) MARKET, BY APPLICATION, 2013-2020 (USD MILLION)
  • TABLE 39: NORTH AMERICA RADIOIMMUNOASSAY (RIA) MARKET, BY TYPE, 2013-2020 (USD MILLION)
  • TABLE 40: NORTH AMERICA RADIOIMMUNOASSAY (RIA) MARKET, BY APPLICATION, 2013-2020 (USD MILLION)
  • TABLE 41: NORTH AMERICA RADIOIMMUNOASSAY (RIA) ANALYZERS MARKET, BY APPLICATION, 2013-2020 (USD MILLION)
  • TABLE 42: NORTH AMERICA RADIOIMMUNOASSAY (RIA) KITS & REAGENTS MARKET, BY APPLICATION, 2013-2020 (USD MILLION)
  • TABLE 43: NORTH-AMERICA RADIOIMMUNOASSAY (RIA) MARKET, BY END-USER, 2013-2020 (USD MILLION)
  • TABLE 44: U.S. RADIOIMMUNOASSAY (RIA) MARKET, BY TYPE, 2013-2020 (USD MILLION)
  • TABLE 45: U.S. RADIOIMMUNOASSAY (RIA) MARKET, BY APPLICATION, 2013-2020 (USD MILLION)
  • TABLE 46: CANADA RADIOIMMUNOASSAY (RIA) MARKET, BY TYPE, 2013-2020 (USD MILLION)
  • TABLE 47: CANADA RADIOIMMUNOASSAY (RIA) MARKET, BY APPLICATION, 2013-2020 (USD MILLION)
  • TABLE 48: MEXICO RADIOIMMUNOASSAY (RIA) MARKET, BY TYPE, 2013-2020 (USD MILLION)
  • TABLE 49: MEXICO RADIOIMMUNOASSAY (RIA) MARKET, BY APPLICATION, 2013-2020 (USD MILLION)
  • TABLE 50: ASIA RADIOIMMUNOASSAY (RIA) MARKET, BY TYPE, 2013-2020 (USD MILLION)
  • TABLE 51: ASIA RADIOIMMUNOASSAY (RIA) MARKET, BY APPLICATION, 2013-2020 (USD MILLION)
  • TABLE 52: ASIA RADIOIMMUNOASSAY (RIA) ANALYZERS MARKET, BY APPLICATION, 2013-2020 (USD MILLION)
  • TABLE 53: ASIA RADIOIMMUNOASSAY (RIA) REAGENTS & KITS MARKET, BY APPLICATION, 2013-2020 (USD MILLION)
  • TABLE 54: ASIA RADIOIMMUNOASSAY (RIA) MARKET, BY END USER, 2013-2020 (USD MILLION)
  • TABLE 55: CHINA RADIOIMMUNOASSAY (RIA) MARKET, BY TYPE, 2013-2020 (USD MILLION)
  • TABLE 56: CHINA RADIOIMMUNOASSAY (RIA) MARKET, BY APPLICATION, 2013-2020 (USD MILLION)
  • TABLE 57: JAPAN RADIOIMMUNOASSAY (RIA) MARKET, BY TYPE, 2013-2020 (USD MILLION)
  • TABLE 58: JAPAN RADIOIMMUNOASSAY (RIA) MARKET, BY APPLICATION, 2013-2020 (USD MILLION)
  • TABLE 59: INDIA RADIOIMMUNOASSAY (RIA) MARKET, BY TYPE, 2013-2020 (USD MILLION)
  • TABLE 60: INDIA RADIOIMMUNOASSAY (RIA) MARKET, BY APPLICATION, 2013-2020 (USD MILLION)
  • TABLE 61: REPUBLIC OF KOREA RADIOIMMUNOASSAY (RIA) MARKET, BY TYPE, 2013-2020 (USD MILLION)
  • TABLE 62: REPUBLIC OF KOREA RADIOIMMUNOASSAY (RIA) MARKET, BY APPLICATION, 2013-2020 (USD MILLION)
  • TABLE 63: ROW RADIOIMMUNOASSAY (RIA) MARKET, BY TYPE, 2013-2020 (USD MILLION)
  • TABLE 64: ROW RADIOIMMUNOASSAY (RIA) MARKET, BY APPLICATION, 2013-2020 (USD MILLION)
  • TABLE 65: ROW RADIOIMMUNOASSAY (RIA) ANALYZERS MARKET, BY APPLICATION, 2013-2020 (USD MILLION)
  • TABLE 66: ROW RADIOIMMUNOASSAY (RIA) REAGENTS & KITS MARKET, BY APPLICATION, 2013-2020 (USD MILLION)
  • TABLE 67: ROW RADIOIMMUNOASSAY (RIA) MARKET, BY END USER, 2013-2020 (USD MILLION)
  • TABLE 68: RADIOIMMUNOASSAY (RIA) KITS MARKET: COMPANY SHARE ANALYSIS, 2014 (%)
  • TABLE 69: RADIOIMMUNOASSAY (RIA) ANALYZERS MARKET: COMPANY SHARE ANALYSIS, 2014 (%)
  • TABLE 70: DIASORIN S.P.A: REVENUE MIX, 2010-2014 (USD MILLION)
  • TABLE 71: MERCK MILLIPORE CORPORATION: KEY FINANCIALS, 2010-2014 (USD MILLION)
  • TABLE 72: STRATEC BIOMEDICAL AG: REVENUE MIX, 2010-2014 (USD MILLION)
  • TABLE 73: DANAHER CORPORATIONS: KEY FINANCIALS, 2011-2014 (USD MILLION)
  • TABLE 74: PERKINELMER, INC.: KEY FINANCIALS, 2010-2014 (USD MILLION)
  • TABLE 75: TECAN TRADING AG: KEY FINANCIALS, 2010-2014 (USD MILLION)

LIST OF FIGURES

  • FIGURE 1: RADIOIMMUNOASSAY (RIA) MARKET SEGMENTATION & COVERAGE
  • FIGURE 2: RADIOIMMUNOASSAY (RIA) MARKET: INTEGRATED ECOSYSTEM
  • FIGURE 3: TOP-DOWN APPROACH
  • FIGURE 4: MACRO INDICATOR-BASED APPROACH
  • FIGURE 5: RADIOIMMUNOASSAY (RIA) MARKET SNAPSHOT, 2014 (%)
  • FIGURE 6: RADIOIMMUNOASSAY (RIA) MARKET, COMPARISON WITH IMMUNOASSAY MARKET (PARENT MARKET), 2013-2020 (USD MILLION)
  • FIGURE 7: RADIOIMMUNOASSAY (RIA) TYPE MARKET, BY TYPE, 2014 & 2020 (USD MILLION)
  • FIGURE 8: RADIOIMMUNOASSAY (RIA) END USER MARKET, BY GEOGRAPHY, 2014 (USD MILLION)
  • FIGURE 9: RADIOIMMUNOASSAY (RIA) APPLICATION MARKET, BY GEOGRAPHY, 2014 (USD MILLION)
  • FIGURE 10: RADIOIMMUNOASSAY (RIA) MARKET, BY TYPE, 2014 & 2020 (USD MILLION)
  • FIGURE 11: RADIOIMMUNOASSAY (RIA) MARKET, TYPE COMPARISON WITH PARENT MARKET, 2013-2020 (USD MILLION)
  • FIGURE 12: RADIOIMMUNOASSAY (RIA) REAGENTS & KITS MARKET, BY GEOGRAPHY, 2014 & 2020 (USD MILLION)
  • FIGURE 13: RADIOIMMUNOASSAY (RIA) ANALYZERS MARKET, BY GEOGRAPHY, 2014 & 2020 (USD MILLION)
  • FIGURE 14: RADIOIMMUNOASSAY (RIA) MARKET, BY END USER, 2014 & 2020 (USD MILLION)
  • FIGURE 15: RADIOIMMUNOASSAY (RIA) HOSPITALS MARKET, BY GEOGRAPHY, 2014 & 2020 (USD MILLION)
  • FIGURE 16: RADIOIMMUNOASSAY (RIA) MARKET IN PHARMACEUTICAL INDUSTRY AND CRO, BY GEOGRAPHY, 2014 & 2020 (USD MILLION)
  • FIGURE 17: RADIOIMMUNOASSAY (RIA) MARKET IN ACADEMICS, BY GEOGRAPHY, 2014 & 2020 (USD MILLION)
  • FIGURE 18: RADIOIMMUNOASSAY (RIA) MARKET IN CLINICAL DIAGNOSTIC LABORATORIES, BY GEOGRAPHY, 2014 & 2020 (USD MILLION)
  • FIGURE 19: RADIOIMMUNOASSAY (RIA) MARKET, BY APPLICATION, 2014 & 2020 (USD MILLION)
  • FIGURE 20: RADIOIMMUNOASSAY (RIA) MARKET IN RESEARCH, BY GEOGRAPHY, 2014 & 2020 (USD MILLION)
  • FIGURE 21: RADIOIMMUNOASSAY (RIA) ANALYZERS MARKET IN RESEARCH APPLICATION, BY GEOGRAPHY, 2014 & 2020 (USD MILLION)
  • FIGURE 22: RADIOIMMUNOASSAY (RIA) KITS & REAGENTS MARKET IN RESEARCH APPLICATION, BY GEOGRAPHY, 2014 & 2020 (USD MILLION)
  • FIGURE 23: RADIOIMMUNOASSAY (RIA) MARKET IN CLINICAL DIAGNOSTICS, BY GEOGRAPHY, 2014 & 2020 (USD MILLION)
  • FIGURE 24: RADIOIMMUNOASSAY (RIA) ANALYZERS MARKET IN CLINICAL DIAGNOSTICS APPLICATION, BY GEOGRAPHY, 2014 & 2020 (USD MILLION)
  • FIGURE 25: RADIOIMMUNOASSAY (RIA) KITS & REAGENTS MARKET IN CLINICAL DIAGNOSTICS APPLICATION, BY GEOGRAPHY, 2014 & 2020 (USD MILLION)
  • FIGURE 26: EUROPE RADIOIMMUNOASSAY (RIA) MARKET OVERVIEW, 2014 & 2020 (%)
  • FIGURE 27: EUROPE RADIOIMMUNOASSAY (RIA) MARKET, BY TYPE, 2014 & 2020 (USD MILLION)
  • FIGURE 28: EUROPE RADIOIMMUNOASSAY (RIA) MARKET, BY APPLICATION, 2014 & 2020 (USD MILLION)
  • FIGURE 29: EUROPE RADIOIMMUNOASSAY MARKET (RIA), BY END USER, 2014 & 2020 (USD MILLION)
  • FIGURE 30: EUROPE RADIOIMMUNOASSAY (RIA) MARKET, BY COUNTRY, 2014 & 2020 (USD MILLION)
  • FIGURE 31: GERMANY RADIOIMMUNOASSAY (RIA) MARKET OVERVIEW, 2014 & 2020 (%)
  • FIGURE 32: FRANCE RADIOIMMUNOASSAY (RIA) MARKET OVERVIEW, 2014 & 2020 (%)
  • FIGURE 33: U.K. RADIOIMMUNOASSAY (RIA) MARKET, OVERVIEW, 2014 & 2020 (%)
  • FIGURE 34: ITALY RADIOIMMUNOASSAY (RIA) MARKET, OVERVIEW 2014 & 2020 (%)
  • FIGURE 35: SPAIN RADIOIMMUNOASSAY (RIA) MARKET OVERVIEW 2014 & 2020 (%)
  • FIGURE 36: NORTH AMERICA RADIOIMMUNOASSAY (RIA) MARKET OVERVIEW, 2014 & 2020 (%)
  • FIGURE 37: NORTH AMERICA RADIOIMMUNOASSAY (RIA) MARKET, BY TYPE, 2014 & 2020 (USD MILLION)
  • FIGURE 38: NORTH AMERICA RADIOIMMUNOASSAY (RIA) MARKET, BY APPLICATION, 2014 & 2020 (USD MILLION)
  • FIGURE 39: NORTH AMERICA RADIOIMMUNOASSAY (RIA) MARKET, BY END USER, 2014 & 2020 (USD MILLION)
  • FIGURE 40: NORTH AMERICA RADIOIMMUNOASSAY (RIA) MARKET, BY COUNTRY, 2014 & 2020, (USD MILLION)
  • FIGURE 41: U.S. RADIOIMMUNOASSAY (RIA) MARKET OVERVIEW 2014 & 2020 (%)
  • FIGURE 42: CANADA RADIOIMMUNOASSAY (RIA) MARKET OVERVIEW, 2014 & 2020 (%)
  • FIGURE 43: MEXICO RADIOIMMUNOASSAY (RIA) MARKET OVERVIEW, 2014 & 2020 (%)
  • FIGURE 44: ASIA RADIOIMMUNOASSAY (RIA) MARKET OVERVIEW, 2014 & 2020 (%)
  • FIGURE 45: ASIA RADIOIMMUNOASSAY (RIA) MARKET, BY TYPE, 2014 & 2020 (USD MILLION)
  • FIGURE 46: ASIA RADIOIMMUNOASSAY (RIA) MARKET, BY APPLICATION, 2014 & 2020 (USD MILLION)
  • FIGURE 47: ASIA RADIOIMMUNOASSAY (RIA) MARKET, BY END USER, 2014 & 2020 (USD MILLION)
  • FIGURE 48: ASIA RADIOIMMUNOASSAY (RIA) MARKET, BY COUNTRY, 2014 & 2020 (USD MILLION)
  • FIGURE 49: CHINA RADIOIMMUNOASSAY (RIA) MARKET OVERVIEW, 2014 & 2020 (%)
  • FIGURE 50: JAPAN RADIOIMMUNOASSAY (RIA) MARKET, OVERVIEW 2014 &2020 (%)
  • FIGURE 51: INDIA RADIOIMMUNOASSAY (RIA) MARKET, OVERVIEW 2014 & 2020 (%)
  • FIGURE 52: REPUBLIC OF KOREA RADIOIMMUNOASSAY (RIA) MARKET, OVERVIEW 2014 & 2020 (%)
  • FIGURE 53: ROW RADIOIMMUNOASSAY (RIA) MARKET OVERVIEW, 2014 & 2020 (%)
  • FIGURE 54: ROW RADIOIMMUNOASSAY (RIA) MARKET, BY COUNTRY, 2014 & 2020 (USD MILLION)
  • FIGURE 55: ROW RADIOIMMUNOASSAY (RIA) MARKET, BY TYPE, 2014 & 2020 (USD MILLION)
  • FIGURE 56: ROW RADIOIMMUNOASSAY (RIA) MARKET, BY APPLICATION, 2014 & 2020 (USD MILLION)
  • FIGURE 57: ROW RADIOIMMUNOASSAY (RIA) MARKET, BY END USER, 2014 & 2020 (USD MILLION)
  • FIGURE 58: RADIOIMMUNOASSAY (RIA) KITS MARKET: COMPANY SHARE ANALYSIS, 2014 (%)
  • FIGURE 59: RADIOIMMUNOASSAY (RIA) ANALYZERS MARKET: COMPANY SHARE ANALYSIS, 2014 (%)
  • FIGURE 60: RADIOIMMUNOASSAY (RIA) MARKET: KEY PLAYERS OPERATING IN APPLICATION AREAS
  • FIGURE 61: RADIOIMMUNOASSAY (RIA) MARKET: COVERAGE OF KEY PLAYERS BY APPLICATION
  • FIGURE 62: DIASORIN S.P.A: REVENUE MIX 2014(%)
  • FIGURE 63: DIASORIN S.P.A: KEY FINANCIALS, 2010-2014 (USD MILLION)
  • FIGURE 64: MERCK MILLIPORE CORPORATION: KEY FINANCIALS, 2010-2014 (USD MILLION)
  • FIGURE 65: STRATEC BIOMEDICAL AG: KEY FINANCIALS, 2010-2014 (USD MILLION)
  • FIGURE 66: DANAHER CORPORATIONS: REVENUE MIX, 2014 (%)
  • FIGURE 67: PERKINELMER, INC.: REVENUE MIX, 2014 (%)
  • FIGURE 68: TECAN TRADING AG: REVENUE MIX, 2014 (%) 107  
Back to Top